SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-19-064705
Filing Date
2019-03-06
Accepted
2019-03-06 07:53:28
Documents
73
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d675303d10k.htm 10-K 1010989
2 EX-10.7 d675303dex107.htm EX-10.7 103109
3 EX-21.1 d675303dex211.htm EX-21.1 2537
4 EX-23.1 d675303dex231.htm EX-23.1 2018
5 EX-31.1 d675303dex311.htm EX-31.1 11117
6 EX-31.2 d675303dex312.htm EX-31.2 11100
7 EX-32.1 d675303dex321.htm EX-32.1 4833
8 EX-32.2 d675303dex322.htm EX-32.2 4809
  Complete submission text file 0001193125-19-064705.txt   8397290

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT galt-20181231.xml EX-101.INS 2185803
10 XBRL TAXONOMY EXTENSION SCHEMA galt-20181231.xsd EX-101.SCH 66212
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20181231_cal.xml EX-101.CAL 26706
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20181231_def.xml EX-101.DEF 428443
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20181231_lab.xml EX-101.LAB 506979
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20181231_pre.xml EX-101.PRE 462250
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 19661271
SIC: 2834 Pharmaceutical Preparations